Buscador de publicaciones

La producción científica de nuestros investigadores es muy elevada. En 2022 se publicaron 1.629 artículos en revistas científicas con un factor de impacto global que superó los 15.000 puntos.

Effects of the extracorporeal membrane oxygenation circuit on plasma levels of ceftolozane.

PMID: 31387460
Revista: PERFUSION-UK
Año: 2020
Referencia: Perfusion. 2020 Apr;35(3):267-270. doi: 10.1177/0267659119864813. Epub 2019 Aug 7.
Factor de impacto: 1.234
Tipo de publicación: Artículo en revista internacional
Autores: Argudo, Eduard, Riera, Jordi, Luque, Sonia, Los-Arcos, Ibai, Lopez-Meseguer, Manuel, Sandiumenge, Alberto, Nuvials, Xavier, Grau, Santiago, Ferrer, Ricard et al.
DOI: 10.1177/0267659119864813

Effects of the extracorporeal membrane oxygenation circuit on plasma levels of ceftolozane.

PMID: 31387460
Revista: PERFUSION-UK
Año: 2020
Referencia: Perfusion. 2020 Apr;35(3):267-270. doi: 10.1177/0267659119864813. Epub 2019 Aug 7.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Argudo, Eduard; Ferrer, Ricard; Grau, Santiago; Lopez-Meseguer, Manuel; Los-Arcos, Ibai; Luque, Sonia; Nuvials, Xavier; Riera, Jordi; Sandiumenge, Alberto et al.
DOI: 10.1177/0267659119864813

Effet de l'Evobrutinib, inhibiteur de la tyrosine kinase de Bruton, sur les taux de cellules immunitaires et d'immunoglobulines sur 48 semaines dans le cadre d'une etude de phase 2 sur la sclerose en plaques recurrente.

PMID: 32906528
Revista: REVUE NEUROLOGIQUE
Año: 2020
Referencia: Rev Neurol (Paris). 2020 Sep;176S:S81. doi: 10.1016/j.neurol.2020.01.242.
Factor de impacto: 1.911
Tipo de publicación: Artículo en revista internacional
Autores: Montalban, Xavier, Shaw, Jamie, Martin, Emily, Grenningloh, Roland, Weber, Martin S, Vermersch, Patrick, Dangond, Fernando et al.
DOI: 10.1016/j.neurol.2020.01.242

Effet de l'Evobrutinib, inhibiteur de la tyrosine kinase de Bruton, sur les taux de cellules immunitaires et d'immunoglobulines sur 48 semaines dans le cadre d'une etude de phase 2 sur la sclerose en plaques recurrente.

PMID: 32906528
Revista: REVUE NEUROLOGIQUE
Año: 2020
Referencia: Rev Neurol (Paris). 2020 Sep;176S:S81. doi: 10.1016/j.neurol.2020.01.242.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Dangond, Fernando; Grenningloh, Roland; Martin, Emily; Montalban, Xavier; Shaw, Jamie; Vermersch, Patrick; Weber, Martin S et al.
DOI: 10.1016/j.neurol.2020.01.242

Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer.

PMID: 31806627
Revista: Cancer Discovery
Año: 2020
Referencia: Cancer Discov. 2020 Feb;10(2):198-213. doi: 10.1158/2159-8290.CD-19-0966. Epub 2019 Dec 5.
Factor de impacto: 29.497
Tipo de publicación: Artículo en revista internacional
Autores: Smyth, Lillian M, Piha-Paul, Sarina A, Won, Helen H, Schram, Alison M, Saura, Cristina, Loi, Sherene, Lu, Janice, Shapiro, Geoffrey I, Juric, Dejan, Scaltriti, Maurizio et al.
DOI: 10.1158/2159-8290.CD-19-0966

Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer.

PMID: 31806627
Revista: Cancer Discovery
Año: 2020
Referencia: Cancer Discov. 2020 Feb;10(2):198-213. doi: 10.1158/2159-8290.CD-19-0966. Epub 2019 Dec 5.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Arnedos, Monica; Arteaga, Carlos L; Baselga, Jose; Bidard, Francois-Clement; Boni, Valentina; Brufksy, Adam M; Bryce, Richard; Cai, Yanyan; Cervantes, Andres; Chandarlapaty, Sarat et al.
DOI: 10.1158/2159-8290.CD-19-0966

Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial.

PMID: 32293523
Revista: Trials
Año: 2020
Referencia: Trials. 2020 Apr 15;21(1):328. doi: 10.1186/s13063-020-4226-2.
Factor de impacto: 1.883
Tipo de publicación: Artículo en revista internacional
Autores: Molina-Morant, D, Fernandez, M L, Bosch-Nicolau, P, Sulleiro, E, Bangher, M, Salvador, F, Sanchez-Montalva, A, Ribeiro, A L P, de Paula, A M B, Eloi, S et al.
DOI: 10.1186/s13063-020-4226-2

Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial.

PMID: 32293523
Revista: Trials
Año: 2020
Referencia: Trials. 2020 Apr 15;21(1):328. doi: 10.1186/s13063-020-4226-2.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Bangher, M; Bosch-Nicolau, P; Correa-Oliveira, R; de Paula, A M B; Eloi, S; Fernandez, M L; Molina, I; Molina-Morant, D; Ribeiro, A L P; Salvador, F et al.
DOI: 10.1186/s13063-020-4226-2

EFFICACY AND SAFETY OF A TREAT-AND-EXTEND REGIMEN WITH AFLIBERCEPT IN TREATMENT-NAIVE PATIENTS WITH TYPE 3 NEOVASCULARIZATION: A 52-Week, Single-Arm, Multicenter Trial.

PMID: 31259813
Revista: RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Año: 2020
Referencia: Retina. 2020 Jul;40(7):1234-1244. doi: 10.1097/IAE.0000000000002582.
Factor de impacto: 3.649
Tipo de publicación: Artículo en revista internacional
Autores: Cervera, Enrique, Vilimelis, Jaume Crespi, Escobar, Jose Juan, Escobar, Antonio Gomez, Zapata, Miguel Angel, Arias, Luis et al.
DOI: 10.1097/IAE.0000000000002582

EFFICACY AND SAFETY OF A TREAT-AND-EXTEND REGIMEN WITH AFLIBERCEPT IN TREATMENT-NAIVE PATIENTS WITH TYPE 3 NEOVASCULARIZATION: A 52-Week, Single-Arm, Multicenter Trial.

PMID: 31259813
Revista: RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Año: 2020
Referencia: Retina. 2020 Jul;40(7):1234-1244. doi: 10.1097/IAE.0000000000002582.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Arias, Luis; Cervera, Enrique; Escobar, Antonio Gomez; Escobar, Jose Juan; Vilimelis, Jaume Crespi; Zapata, Miguel Angel et al.
DOI: 10.1097/IAE.0000000000002582

Efficacy and safety of bortezomib in refractory lupus nephritis: a single-center experience.

PMID: 31865857
Revista: LUPUS
Año: 2020
Referencia: Lupus. 2020 Feb;29(2):118-125. doi: 10.1177/0961203319896018. Epub 2019 Dec 22.
Factor de impacto: 2.251
Tipo de publicación: Artículo en revista internacional
Autores: Segarra, A, Arredondo, K V, Jaramillo, J, Jatem, E, Salcedo, M T, Agraz, I, Ramos, N, Carnicer, C, Valtierra, N, Ostos, E et al.
DOI: 10.1177/0961203319896018

Efficacy and safety of bortezomib in refractory lupus nephritis: a single-center experience.

PMID: 31865857
Revista: LUPUS
Año: 2020
Referencia: Lupus. 2020 Feb;29(2):118-125. doi: 10.1177/0961203319896018. Epub 2019 Dec 22.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Agraz, I; Arredondo, K V; Carnicer, C; Jaramillo, J; Jatem, E; Ostos, E; Ramos, N; Salcedo, M T; Segarra, A; Valtierra, N et al.
DOI: 10.1177/0961203319896018

Efficacy and safety of hydroxychloroquine in healthcare professionals with mild SARS-CoV-2 infection: Prospective, non-randomized trial.

PMID: 33413989
Revista: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Año: 2020
Referencia: Enferm Infecc Microbiol Clin (Engl Ed). 2020 Dec 9. pii: S0213-005X(20)30413-4. doi: 10.1016/j.eimc.2020.10.023.
Factor de impacto: 1.654
Tipo de publicación: Artículo en revista nacional
Autores: Alonso, Manuel, Espuga, Meritxell, Esperalba, Juliana, Gorgas, M feminine Queralt, Almirante, Benito, Ribera, Esteban, Andres, Cristina, Vidal, Xavier, Anton, Andres, Agusti, Antonia et al.
DOI: 10.1016/j.eimc.2020.10.023

Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial.

PMID: 32880601
Revista: JAMA Oncology
Año: 2020
Referencia: JAMA Oncol. 2020 Oct 1;6(10):1571-1580. doi: 10.1001/jamaoncol.2020.3370.
Factor de impacto: 24.799
Tipo de publicación: Artículo en revista internacional
Autores: Van Cutsem, Eric, Shitara, Kohei, Tabernero, Josep, Shah, Sukrut, Wyrwicz, Lucjan, Lee, Keun-Wook, Kudaba, Iveta, Garrido, Marcelo, Chung, Hyun Cheol, Lee, Jeeyun et al.
DOI: 10.1001/jamaoncol.2020.3370

Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial.

PMID: 32880601
Revista: JAMA Oncology
Año: 2020
Referencia: JAMA Oncol. 2020 Oct 1;6(10):1571-1580. doi: 10.1001/jamaoncol.2020.3370.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Alsina, Maria; Bang, Yung-Jue; Benson, Al; Braghiroli, Maria Ignez; Caglevic, Christian; Castro, Hugo Raul; Chao, Joseph; Chung, Hyun Cheol; Enzinger, Peter; Fuchs, Charles et al.
DOI: 10.1001/jamaoncol.2020.3370

Efficacy and Safety of the Combination of Pravastatin and Sorafenib for the Treatment of Advanced Hepatocellular Carcinoma (ESTAHEP Clinical Trial).

PMID: 32674461
Revista: Cancers
Año: 2020
Referencia: Cancers (Basel). 2020 Jul 14;12(7). pii: cancers12071900. doi: 10.3390/cancers12071900.
Factor de impacto: 6.126
Tipo de publicación: Artículo en revista internacional
Autores: Arenas, Juan I, Banales, Jesus M, Perugorria, Maria J, Minguez, Beatriz, Riano, Ioana, Martin, Leticia, Varela, Maria, Serrano, Trinidad, Nunez, Oscar, Rodrigues, Pedro M et al.
DOI: 10.3390/cancers12071900

Efficacy and Safety of the Combination of Pravastatin and Sorafenib for the Treatment of Advanced Hepatocellular Carcinoma (ESTAHEP Clinical Trial).

PMID: 32674461
Revista: Cancers
Año: 2020
Referencia: Cancers (Basel). 2020 Jul 14;12(7). pii: cancers12071900. doi: 10.3390/cancers12071900.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Arenas, Juan I; Banales, Jesus M; Martin, Leticia; Minguez, Beatriz; Nunez, Oscar; Perugorria, Maria J; Riano, Ioana; Rodrigues, Pedro M; Serrano, Trinidad; Varela, Maria et al.
DOI: 10.3390/cancers12071900

Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy: Subgroup Analyses of a Randomized Clinical Trial.

PMID: 31600365
Revista: JAMA Oncology
Año: 2020
Referencia: JAMA Oncology. 2020 Jan 9;6(1):e193531. doi: 10.1001/jamaoncol.2019.3531.
Factor de impacto: 24.799
Tipo de publicación: Artículo en revista internacional
Autores: Prokharau, Aliaksandr, Arkenau, Hendrik-Tobias, Ghidini, Michele, Fujitani, Kazumasa, Van Cutsem, Eric, Thuss-Patience, Peter, Beretta, Giordano D, Mansoor, Wasat, Zhavrid, Edvard, Alsina, Maria et al.
DOI: 10.1001/jamaoncol.2019.3531

Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy: Subgroup Analyses of a Randomized Clinical Trial.

PMID: 31600365
Revista: JAMA Oncology
Año: 2020
Referencia: JAMA Oncology. 2020 Jan 9;6(1):e193531. doi: 10.1001/jamaoncol.2019.3531.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Alsina, Maria; Arkenau, Hendrik-Tobias; Beretta, Giordano D; Catenacci, Daniel; Doi, Toshihiko; Fujitani, Kazumasa; George, Ben; Ghidini, Michele; Ilson, David H; Makris, Lukas et al.
DOI: 10.1001/jamaoncol.2019.3531

Efficacy and tolerability of perampanel as a first add-on therapy with different anti-seizure drugs.

PMID: 33096456
Revista: SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
Año: 2020
Referencia: Seizure. 2020 Dec;83:48-56. doi: 10.1016/j.seizure.2020.09.026. Epub 2020 Oct 7.
Factor de impacto: 2.522
Tipo de publicación: Artículo en revista internacional
Autores: Davila-Gonzalez, Pablo, Santamarina, Estevo, Bertol, Vicente, Garayoa, Vanesa, Garcia-Gomara, Maria Jose, Garamendi-Ruiz, Inigo, Giner, Pau, Aranzabal, Ines, Piera, Anna, Arcos, Carolina et al.
DOI: 10.1016/j.seizure.2020.09.026

Efficacy and tolerability of perampanel as a first add-on therapy with different anti-seizure drugs.

PMID: 33096456
Revista: SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
Año: 2020
Referencia: Seizure. 2020 Dec;83:48-56. doi: 10.1016/j.seizure.2020.09.026. Epub 2020 Oct 7.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Aranzabal, Ines; Arcos, Carolina; Bertol, Vicente; Bonet, Macarena; Casadevall, Teresa; Davila-Gonzalez, Pablo; de Tienda, Alejandro Ponz; Esteve, Patricia; Garamendi-Ruiz, Inigo; Garayoa, Vanesa et al.
DOI: 10.1016/j.seizure.2020.09.026

Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients-a randomized clinical trial.

PMID: 32131866
Revista: CRITICAL CARE
Año: 2020
Referencia: Crit Care. 2020 Mar 4;24(1):74. doi: 10.1186/s13054-020-2792-z.
Factor de impacto: 6.407
Tipo de publicación: Artículo en revista internacional
Autores: Schneider, Hauke, Kanesa-Thasan, Niranjan, Eder-Lingelbach, Susanne, Klingler, Anton, Dubischar, Katrin, Wressnigg, Nina, Rello, Jordi, Sramek, Vladimir, Hejja, Maria, Schaaf, Bernhard et al.
DOI: 10.1186/s13054-020-2792-z

Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients-a randomized clinical trial.

PMID: 32131866
Revista: CRITICAL CARE
Año: 2020
Referencia: Crit Care. 2020 Mar 4;24(1):74. doi: 10.1186/s13054-020-2792-z.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Adlbrecht, Christopher; Creteur, Jacques; Depuydt, Pieter; Dubischar, Katrin; Eder-Lingelbach, Susanne; Eller, Philipp; Hejja, Maria; Kanesa-Thasan, Niranjan; Klingler, Anton; Laenen, Margot Vander et al.
DOI: 10.1186/s13054-020-2792-z

Efficacy of a Multicomponent Intervention for Fibromyalgia Based on Pain Neuroscience Education, Exercise Therapy, Psychological Support, and Nature Exposure (NAT-FM): Study Protocol of a Randomized Controlled Trial.

PMID: 31963773
Revista: International Journal of Environmental Research and Public Health
Año: 2020
Referencia: Int J Environ Res Public Health. 2020 Jan 19;17(2). pii: ijerph17020634. doi: 10.3390/ijerph17020634.
Factor de impacto: 2.849
Tipo de publicación: Artículo en revista internacional
Autores: Serrat, Mayte, Sanabria-Mazo, Juan P, Garcia-Troiteiro, Elna, Fontcuberta, Anna, Mateo-Canedo, Corel, Almirall, Miriam, Feliu-Soler, Albert, Mendez-Ulrich, Jorge Luis, Sanz, Antoni, Luciano, Juan V et al.
DOI: 10.3390/ijerph17020634

Publicaciones

Buscador de publicaciones

Effects of the extracorporeal membrane oxygenation circuit on plasma levels of ceftolozane.

Effects of the extracorporeal membrane oxygenation circuit on plasma levels of ceftolozane.

Effet de l'Evobrutinib, inhibiteur de la tyrosine kinase de Bruton, sur les taux de cellules immunitaires et d'immunoglobulines sur 48 semaines dans le cadre d'une etude de phase 2 sur la sclerose en plaques recurrente.

Effet de l'Evobrutinib, inhibiteur de la tyrosine kinase de Bruton, sur les taux de cellules immunitaires et d'immunoglobulines sur 48 semaines dans le cadre d'une etude de phase 2 sur la sclerose en plaques recurrente.

Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer.

Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer.

Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial.

Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial.

EFFICACY AND SAFETY OF A TREAT-AND-EXTEND REGIMEN WITH AFLIBERCEPT IN TREATMENT-NAIVE PATIENTS WITH TYPE 3 NEOVASCULARIZATION: A 52-Week, Single-Arm, Multicenter Trial.

EFFICACY AND SAFETY OF A TREAT-AND-EXTEND REGIMEN WITH AFLIBERCEPT IN TREATMENT-NAIVE PATIENTS WITH TYPE 3 NEOVASCULARIZATION: A 52-Week, Single-Arm, Multicenter Trial.

Efficacy and safety of bortezomib in refractory lupus nephritis: a single-center experience.

Efficacy and safety of bortezomib in refractory lupus nephritis: a single-center experience.

Efficacy and safety of hydroxychloroquine in healthcare professionals with mild SARS-CoV-2 infection: Prospective, non-randomized trial.

Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial.

Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial.

Efficacy and Safety of the Combination of Pravastatin and Sorafenib for the Treatment of Advanced Hepatocellular Carcinoma (ESTAHEP Clinical Trial).

Efficacy and Safety of the Combination of Pravastatin and Sorafenib for the Treatment of Advanced Hepatocellular Carcinoma (ESTAHEP Clinical Trial).

Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy: Subgroup Analyses of a Randomized Clinical Trial.

Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy: Subgroup Analyses of a Randomized Clinical Trial.

Efficacy and tolerability of perampanel as a first add-on therapy with different anti-seizure drugs.

Efficacy and tolerability of perampanel as a first add-on therapy with different anti-seizure drugs.

Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients-a randomized clinical trial.

Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients-a randomized clinical trial.

Efficacy of a Multicomponent Intervention for Fibromyalgia Based on Pain Neuroscience Education, Exercise Therapy, Psychological Support, and Nature Exposure (NAT-FM): Study Protocol of a Randomized Controlled Trial.

Patronato:

Colabora:

Acreditaciones: